Literature DB >> 3118792

Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.

N Høiby1, G Döring, P O Schiøtz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118792

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


× No keyword cloud information.
  15 in total

1.  AlgR, a response regulator controlling mucoidy in Pseudomonas aeruginosa, binds to the FUS sites of the algD promoter located unusually far upstream from the mRNA start site.

Authors:  C D Mohr; N S Hibler; V Deretic
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

2.  Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.

Authors:  Marc B Habash; Amber J Park; Emily C Vis; Robert J Harris; Cezar M Khursigara
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

3.  Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen.

Authors:  C Koch; N Høiby
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

4.  Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.

Authors:  Manish Bodas; Taehong Min; Steven Mazur; Neeraj Vij
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

5.  Morphological and immunohistochemical studies of the lungs and bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with Pseudomonas aeruginosa.

Authors:  M Iwata; A Sato
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 6.  Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors:  N Høiby; C Koch
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

7.  Enzymic and permeability activity of Pseudomonas aeruginosa after treatment with sub-MICs of organic ammonium salts.

Authors:  A Hostacká; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

8.  Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.

Authors:  A Brauner; S J Cryz; M Granström; H S Hanson; L Löfstrand; B Strandvik; B Wretlind
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

9.  AlgR-binding sites within the algD promoter make up a set of inverted repeats separated by a large intervening segment of DNA.

Authors:  C D Mohr; J H Leveau; D P Krieg; N S Hibler; V Deretic
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

10.  Immunocytochemical analysis of AlgP (Hp1), a histonelike element participating in control of mucoidy in Pseudomonas aeruginosa.

Authors:  V Deretic; N S Hibler; S C Holt
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.